Elsevier whitepaper

Meeting pharmacovigilance and medical device post-market surveillance requirements

Elsevier R&D Solutions for Pharma and Life Science: extracts from Elsevier’s whitepaper  THE FUNDAMENTALS OF MONITORING LITERATURE Monitoring literature for product citations would be an impossible task if not for modern research informatics solutions. Corporate, academic and government pharmaceutical and medical research facilities produce in excess of 20 terabytes of data per day. Even with only a fraction of this data …

Robin Geller, Baxter Healthcare Corporation, on the #Pharmacovigilance industry

Continuing with our series on the current pharmacovigilance industry we spoke with Robin Geller, Director of Risk Management and Safety Writing Global Pharmacovigilance, at Baxter Healthcare Corporation What is the biggest change that you are seeing in pharma's drug safety strategies at the moment? The continuing shift from submission of individual case reports to aggregate analysis, signal detection and risk …

Topics to be covered at #DrugSafety Europe

If you can't make our Drug Safety USA event taking place next week, why not check out our European event coming up in September? The brochure is due out in a few weeks but see below for a sneak preview of some of the presentations due to take place: In depth review of the new European pharmacovigilance legislation Operational implications …

Who has previously attended Drug Safety World?

  The World Drug Safety Congress Americas will provide you with the opportunity to meet and network with the big names in the industry. If you are thinking of attending but aren't sure who will be there, check out the list below of previous companies who have come to the event in the past.   If you are interested in …